再生醫學市場：按組織類型、應用、最終用戶和地區分類

Regenerative Therapies Market, By Tissue Type, By Application type, By End user, By Geography

出版日期: 2025年11月07日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年再生醫學市場規模預計為 1,252.5 億美元，預計到 2032 年將達到 3,476.3 億美元，2025 年至 2032 年的複合年成長率為 15.7%。

分析範圍		分析詳情
基準年	2024	市場規模（2025 年）	1252.5億美元
效能數據	2020-2024	預測期	2025-2032
預測期（2025-2032 年）複合年成長率	15.70%	預計金額（2032 年）	3476.3億美元

再生醫學是一種以幹細胞為基礎的治療方法，也是醫學領域發展最快的領域之一。老齡化和損傷會導致人體難以獲得維持正常功能所需的最佳幹細胞數量。再生醫學的目標是增強人體自身的自然癒合能力，並滿足患者的需求。整形外科是再生醫學的一個分支，它透過刺激肌肉骨骼系統中的細胞再生來利用人體自身的癒合過程。 Histogen是整形外科再生醫學產品的生產商之一。其生產的人類細胞外基質（hECM）具有抗發炎和血管生成特性，能夠促進損傷部位的幹細胞生長，進而誘導組織再生。

市場動態

由於對修復和再生受損組織和器官的創新療法的需求不斷成長，再生醫學市場正經歷快速擴張。幹細胞療法、組織工程和基因療法的進步塑造了市場動態，並推動了市場成長。儘管面臨成本和監管複雜性方面的挑戰，但持續的技術進步和研發投入的增加正在推動市場向前發展。隨著人們意識的提高和臨床證據的積累，再生醫學市場有望透過提供創新解決方案和改善患者預後，從而改變醫療保健產業。

全球再生醫學市場阻礙因素

組織工程和生物醫學工程領域缺乏標準化指南預計將阻礙全球再生醫學市場的成長。此外，由於臨床試驗週期過長導致產品上市延遲，預計也會抑制市場成長。

本報告的主要特點

本報告對全球再生醫學市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和複合年成長率。
它還重點介紹了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的關鍵見解。
該報告根據公司概況、產品系列、主要亮點、財務表現和策略等參數，對全球再生醫學市場的主要企業進行了分析。
本報告提供的見解將使負責人和企業經營團隊能夠就未來的產品發布、合作關係、市場擴張和行銷策略做出明智的決策。
《全球再生醫學市場》報告面向該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過各種用於分析全球再生醫學市場的策略矩陣，更輕鬆地做出決策。

公司簡介
- Shire Pharmaceuticals
- Kinetic Concepts, Inc.
- Mesoblast Ltd.
- Metcela Inc.
- Nuo Therapeutics（Cytomedix Inc.）
- Integra LifeSciences
- Advanced Cell Technology, Inc.
- BioStem Life Sciences
- Akron Biotechnology, LLC
- Organovo Holdings Inc.
- Orgenesis Inc.
- Pluristem Therapeutics Inc.
- Genzyme
- Athersys, Inc.
- RenovaCare, Inc.
- Cytori Therapeutics, Inc.

第9章各節

參考
分析方法

簡介目錄

Product Code: CMI3712

Regenerative Therapies Market is estimated to be valued at USD 125.25 Bn in 2025 and is expected to reach USD 347.63 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 125.25 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	15.70%	2032 Value Projection:	USD 347.63 Bn

Regenerative medicine is one the fastest emerging fields of medicine, as it adopts stem cells for treatment. Increasing age or injury, makes it difficult to provide the optimum amount of stem cells that are needed to maintain the normal function. The goal of regenerative medicine is to amplify this natural repair system to keep pace with the demands of the patients. Orthopedics is one of the fields of regenerative medicine, which adopts natural healing process by stimulating regeneration of cells in the musculoskeletal system. Histogen Inc. is one of the manufacturer of orthopedic regenerative medicine and its product Human Extracellular matrix (hECM) is anti-inflammatory, angiogenic, and can stimulate growth of stem cells in damaged areas to induce tissue regeneration.

Market Dynamics

The regenerative therapy market is witnessing rapid expansion due to the increasing demand for innovative treatments that can restore and regenerate damaged tissues and organs. Market dynamics are being shaped by advancements in stem cell therapies, tissue engineering, and gene therapy, which are driving the market's growth. Despite challenges related to cost and regulatory complexities, continuous technological advancements and growing investments in research and development are driving the market forward. As awareness grows and clinical evidence accumulates, the regenerative therapy market is poised to transform healthcare by offering transformative solutions and improving patient outcomes.

Restraints of the Global Regenerative Therapies Market

Lack of standardized guidelines on tissue and bio-medical engineering is expected to hinder growth of the global regenerative therapies market. Moreover, lengthy clinical trials leading to delayed entry of products in the market is expected to restrain growth of the market.

Key features of the study

This report provides in-depth analysis of the global regenerative therapies market and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global regenerative therapies market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Shire Pharmaceuticals, Kinetic Concepts, Inc., Mesoblast Ltd., Metcela Inc., Nuo Therapeutics (Cytomedix Inc.), Integra LifeSciences, Advanced Cell Technology Inc., BioStem Life Sciences,Akron Biotechnology, LLC, Organovo Holdings Inc., Orgenesis Inc., Pluristem Therapeutics Inc., Genzyme, Athersys, Inc., RenovaCare, Inc., Cytori Therapeutics, Inc.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global regenerative therapies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Market Segmentation

Global Regenerative Therapies Market, By Tissue Type
- Allograft
- Xenograft
- Alloplast
Global Regenerative Therapies Market, By Application
- Soft Tissue Repair
- Cardiovascular
- Dental
- Orthopedic
- CNS disease treatment
- Others
Global Regenerative Therapies Market, By End User
- Hospitals
- Ambulatory Surgical Centers
- Educational Institutes
Global Regenerative Therapies Market, By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- Central Africa
- South Africa
- North Africa
Company Profiles
- Shire Pharmaceuticals
- Kinetic Concepts, Inc.
- Mesoblast Ltd.
- Metcela Inc.
- Nuo Therapeutics (Cytomedix Inc.)
- Integra LifeSciences
- Advanced Cell Technology, Inc.
- BioStem Life Sciences
- Akron Biotechnology, LLC
- Organovo Holdings Inc.
- Orgenesis Inc.
- Pluristem Therapeutics Inc.
- Genzyme
- Athersys, Inc.
- RenovaCare, Inc.
- Cytori Therapeutics, Inc.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Tissue Type
- Market Snippet, By Application
- Market Snippet, By End User
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Developments
Regulatory Scenario
PEST Analysis

4. Global Regenerative Therapies Market, By Tissue Type, 2020-2032(US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032(%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Allograft
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Xenograft
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Alloplast
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends

5. Global Regenerative Therapies Market, By Application, 2020-2032(US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032(%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Soft Tissue Repair
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Dental
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Orthopedic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
CNS disease treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

6. Global Regenerative Therapies Market, By End User, 2020-2032(US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032(%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Educational Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

7. Global Regenerative Therapies Market, By Regions, 2020-2032(US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032(%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Company Profiles
- Shire Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Kinetic Concepts, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Mesoblast Ltd.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Metcela Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Nuo Therapeutics (Cytomedix Inc.)
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Integra LifeSciences
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Advanced Cell Technology, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- BioStem Life Sciences
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Akron Biotechnology, LLC
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Organovo Holdings Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Orgenesis Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pluristem Therapeutics Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Genzyme
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Athersys, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- RenovaCare, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Cytori Therapeutics, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies